Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant Recipients-Reference-Cited by-同舟云学术

Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant Recipients

Published:2002-10 Issue:7 Volume:35 Page:866-872
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Limaye Ajit P.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/35/7/866/873003/35-7-866.pdf

Reference39 articles.

1. Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients

2. Cytomegalovirus (CMV) Culture Results, Drug Resistance, and Clinical Outcome in Patients with AIDS and CMV Retinitis Treated with Foscarnet or Ganciclovir

3. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma.

4. Smith IL, Flores-Aguilar M, Taskituna I, Jiles RE, Freeman WR, Spector SA. Cytomegalovirus resistance is associated with clinical failure in AIDS patients receiving ganciclovir treatment for retinitis [abstract H30]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996.

5. Antiviral drug resistance in human cytomegalovirus

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detecting drug-resistant human cytomegalovirus mutations in liver transplant recipients: A study of the UL97 gene;Gene Reports;2024-09

2. HerpesDRG: a comprehensive resource for human herpesvirus antiviral drug resistance genotyping;BMC Bioinformatics;2024-08-27

3. Prevalence Of Cytomegalovirus Infection In Patients Attending A Tertiary Care Hospital - Single Centre Experience;2024-08-23

4. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients;Transplant Infectious Disease;2024-06

5. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir;Infectious Disease Reports;2024-01-18